Curcumin & Astaxanthin for Lowering Triglyceride Readings and Inflammation
Curcumin and Astaxanthin for Lowering Triglyceride Readings and Inflammation
Medinutra LLC
64 participants
Jul 18, 2025
INTERVENTIONAL
Conditions
Summary
Two dietary supplements are each being compared to a placebo for the ability to help maintain triglycerides in the normal range. The subjects will be adult men and women with moderately high TG values. Serum triglycerides will be measured before and after 6 weeks of taking 1 capsule per day of either Longvida Curcumin, astaxanthin, or a placebo. A few side blood analysis will also be done. These measures are relevant to low level inflammation.
Eligibility
Inclusion Criteria2
- Triglyceride reading of 140-250 mg/dL
- Age 21-59
Exclusion Criteria12
- Uncontrolled diabetes
- Hypothyroidism or other hormonal problems that have not stabilized
- Any liver diseases being actively treated
- Cancer
- Renal dialysis use
- Rheumatoid arthritis and related issues like lupus
- Inflammatory bowel disease
- Smoking
- Low blood pressure
- Having more than 5 alcoholic drinks per week
- Extreme obesity (BMI over 37)
- Pregnancy or lactation
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
1 capsule per day at a usual curcumin dose for this particular product (80 mg curcumin)
1 capsule per day at half the usual curcumin dose for this particular product (40 mg curcumin as the half dose)
1 capsule per day at a usual astaxanthin dose (12 mg)
Subject will get 1 capsule per day of a small amount of cellulose
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07063056